Interpretation
Current cases are analysed and reported in accordance with CAP/ASCO recommendations (2013):
Wolff et al: Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update. J Clin Oncol. 2013 Nov 31(31): 3997-4014.
For cases received prior to 1st November 2013, the CAP/ASCO Guidelines (2007) were followed:
Wolff A C, et al. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. J Clin Oncol. 2007 Jan 1;25(1): 118-45.
Please contact this laboratory if you have any questions regarding these changes.
Test Method
Fluorescence in situ hybridisation (FISH) on formalin fixed paraffin embedded tissue (FFPE) slides using a probe specific to the HER2 (ERBB2) locus and a chromosome 17 control probe.